Elrexfio 44 mg/1.1mL (Elranatamab-Bcmm INJECTION, SOLUTION) 44 mg/1.1mL

Elrexfio 44 mg/1.1mL is a subcutaneous injection solution containing elranatamab-bcmm. This medication is used for specific therapeutic purposes and is supplied in single-dose vials. Learn more about its uses and effects.

Strength

44 mg/1.1mL

Pack Size

1 VIAL, SINGLE-DOSE in 1 CARTON (0069-2522-02) / 1.1 mL in 1 VIAL, SINGLE-DOSE (0069-2522-01)

Manufacturer / TM Owner

Pfizer Laboratories Div Pfizer Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Elrexfio 44 mg/1.1mL is primarily used for targeted therapeutic applications. It is administered subcutaneously and is designed to address certain medical conditions. The specific uses of Elrexfio may vary, and it is important to consult healthcare professionals for detailed information on what Elrexfio is used for.

Side Effects

Common effects of Elrexfio 44 mg/1.1mL may include localized reactions at the injection site. Some individuals might experience general side effects, but these can vary widely among users. It is essential to monitor for any unusual symptoms and report them to a healthcare provider.

Precautions & Warnings

Elrexfio 44 mg/1.1mL should be handled with care, ensuring proper storage and administration techniques. It is crucial to follow the guidelines provided by healthcare professionals to minimize the risk of adverse reactions. Always use this medication as directed and avoid self-administration without proper medical supervision.

Avoid Interactions

Elrexfio 44 mg/1.1mL may interact with certain substances, including other medications and alcohol. It is important to inform healthcare providers about all current medications and substances being used to avoid potential interactions. Always consult a healthcare professional before starting or stopping any medication.

Frequently Asked Questions

Elrexfio 44 mg/1.1mL is used for specific therapeutic purposes, typically involving targeted medical conditions. Consult a healthcare professional for detailed information on its uses.

Elrexfio 44 mg/1.1mL is administered subcutaneously, usually by a healthcare professional. It is supplied in single-dose vials for precise dosing.

Common effects may include localized reactions at the injection site. Some individuals might experience general side effects, which can vary widely.

Yes, it is important to handle Elrexfio 44 mg/1.1mL with care, follow storage guidelines, and administer it as directed by a healthcare professional.

Yes, Elrexfio 44 mg/1.1mL may interact with other medications and substances. Always inform your healthcare provider about all current medications to avoid potential interactions.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.